Dependence of oxygen consumption on oxygen delivery in patients with chronic congestive heart failure

Regional Metabolic Supply Dependency in Chronic Congestive Heart Failure

We present a 64-year-old man with New York Heart Association (NYHA) Class III chronic congestive heart failure (CHF) who was examined for an alteration in cerebral cortex regional oxygen utilization as reflected by changes in local cerebral metabolic rates for glucose (LCMRglu). LCMRglu was determined by positron emission tomography at baseline and while oxygen delivery (DO2) was optimized during dobutamine infusion. Baseline DO2 was 8.31 mL/min/kg and cardiac output (CO) was 3.4 L/min, whereas oxygen consumption (VO2) measured by respired gas analysis was 3.64 mL/min/kg. At optimal dobutamine effect (7.5 μg/kg/min), DO2 increased to 16.8 mL/min/kg, CO to 7.2 L/min, and VO2MEAS was 3.67 mL/min/kg. Mean percentage Increase in cortical gray matter LCMRglu was 99.4 ± 11.7% (mean ± SD) and was statistically significant ( p < 0.001; Student's paired t-test). Our results demonstrate that the cerebral glucose utilization and therefore oxygen consumption increased parallel with Increases in DO2. This phenomenon is contrary to the conventional concept that cerebral perfusion is strictly autoregulated and that substrate utilization is independent of oxygen delivery.

Can we better estimate resting oxygen consumption by incorporating arterial blood gases and spirometric determinations?

BACKGROUND

We hypothesize that oxygen consumption (V̇o2) estimation in patients with respiratory symptoms is inaccurate and can be improved by considering arterial blood gases or spirometric variables.

METHODS

For this retrospective study, we included consecutive subjects who underwent cardiopulmonary exercise testing. Resting V̇o2 was determined using breath-by-breath testing methodology. Using a training cohort (n = 336), we developed 3 models to predict V̇o2. In a validation group (n = 114), we compared our models with 7 available formulae.

RESULTS

Our first model (V̇o2 = -184.99 + 189.64 × body surface area [BSA, m(2)] + 1.49 × heart rate [beats/min] + 51.51 × FIO2 [21% = 0; 30% = 1] + 30.62 × gender [male = 1; female = 0]) showed an R(2) of 0.5. Our second model (V̇o2 = -208.06 + 188.67 × BSA + 1.38 × heart rate + 35.6 × gender + 2.06 × breathing frequency [breaths/min]) showed an R(2) of 0.49. The best R(2) (0.68) was obtained with our last model, which included minute ventilation (V̇o2 = -142.92 + 0.52 × heart rate + 126.84 × BSA + 14.68 × minute ventilation [L]). In the validation cohort, these 3 models performed better than other available equations, but had wide limits of agreement, particularly in older individuals with shorter stature, higher heart rate, and lower maximum voluntary ventilation.

CONCLUSIONS

We developed more accurate formulae to predict resting V̇o2 in subjects with respiratory symptoms; however, equations had wide limits of agreement, particularly in certain groups of subjects. Arterial blood gases and spirometric variables did not significantly improve the predictive equations.

Clarification of cyanide's effect on oxygen transport characteristics in a canine model

OBJECTIVE

To clarify the cardiovascular mechanisms of cyanide poisoning by evaluating oxygen transport characteristics using a canine model.

METHODS

A prospective controlled experiment was performed at a hospital-based animal laboratory. Five male beagle (17 (2) kg) dogs were anesthetised with alpha-chloralose, paralysed with pancuronium bromide and mechanically ventilated. Potassium cyanide was infused at 0.045 mg/kg/min for 110 min. Heart rate, blood pressure, cardiac output, oxygen delivery (DO2), oxygen consumption (VO2) and oxygen extraction ratio (OER) were measured every 10 min for 140 min. DO2 was measured by an indirect calorimeter.

RESULTS

Cyanide and lactate levels peaked at 1.52 (0.25) mg/l and 9.1 (1.5) mmol/l, respectively. Systolic blood pressure remained relatively constant whereas diastolic blood pressure decreased by 19%. Cardiac output, heart rate and DO2 increased to a maximum of 6%, 10% and 10%, respectively, at 40 min, after which they declined to a low of 32%, 28% and 30% below baseline, respectively. Stroke volume remained constant. Oxygen consumption initially increased by 5%, then decreased to 24% below baseline. The OER initially declined to 35% below baseline, then increased throughout the rest of the study.

CONCLUSION

Cyanide poisoning in the canine model showed two phases of injury. The first (compensated) phase had a mechanism consistent with a traditional global oxygen consumption defect. The second (decompensated) phase had a mechanism consistent with heart failure. This heart failure was due to bradycardia. These data suggest chronotropy as an avenue of further study in the temporary treatment of cyanide poisoning.

Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheyne-Stokes respiration and congestive heart failure

STUDY OBJECTIVES

The mechanism(s) by which nasal continuous positive airway pressure (CPAP) is effective in the treatment of Cheyne-Stokes respiration (CSR) in patients with congestive heart failure (CHF) remains uncertain, and may involve an increase in total oxygen body stores (dampening), changes in central and peripheral controller gain, and/or improvement in cardiac function. The purpose of this study was to evaluate the effects of nasal CPAP on total oxygen stores, as measured by the rate of fall of arterial oxyhemoglobin saturation (dSaO(2)/dt), to determine if dampening may play a role in the attenuation of CSR in patients with CHF.

DESIGN

Prospective controlled trial.

SETTING

University hospital.

PATIENTS

Nine male patients (mean +/- SD age, 59 +/- 8 years) with CHF and a mean left ventricular ejection fraction (LVEF) of 16 +/- 4%.

INTERVENTIONS AND MEASUREMENTS

All patients had known CSR, as identified on a baseline polysomnographic study. Patients then underwent repeat polysomnography while receiving nasal CPAP (9 +/- 0.3 cm H(2)O). The polysomnography consisted of recording of breathing pattern, pulse oximetry, and EEG. dSaO(2)/dt was measured as the slope of a line drawn adjacent to the falling linear portion of the arterial oxygen saturation (SaO(2)) curve associated with a central apnea. All patients underwent echocardiography and right-heart catheterization within 1 month of the study to measure LVEF and cardiac hemodynamics, respectively.

RESULTS

There was a significant decrease in the apnea-hypopnea index (AHI) with nasal CPAP, from 44 +/- 27 events per hour at baseline to 15 +/- 24 events per hour with nasal CPAP (p = 0.004). When compared to baseline, dSaO(2)/dt significantly decreased with nasal CPAP from 0.42 +/- 0.15% to 0.20 +/- 0.07%/s (p < 0.001). The postapneic SaO(2), when compared to baseline, significantly increased with nasal CPAP, from 87 +/- 5% to 91 +/- 4% (p < 0.05). The preapneic SaO(2) did not significantly change, from a baseline of 96 +/- 2% to 96 +/- 3% with nasal CPAP (p = 0.8). When compared to baseline, the apnea duration and heart rate did not change with nasal CPAP. While there was a significant correlation noted between baseline postapneic SaO(2) and dSaO(2)/dt (r = 0.8, p = 0.02), no correlation was seen between baseline preapneic SaO(2) and dSaO(2)/dt (r = 0.1, p = 0.7). A significant correlation was noted between baseline dSaO(2)/dt and the AHI (r = 0.7, p = 0.02). With CPAP, there was a significant correlation noted between dSaO(2)/dt and the AHI (R = 0.7, p = 0.04), but no correlation was noted between dSaO(2)/dt and postapneic SaO(2) (R = 0.1, p = 0.8).

CONCLUSION

Nasal CPAP significantly decreases dSaO(2)/dt and thus increases total body oxygen stores in patients with CSR and CHF. By increasing oxygen body stores, dampening may be one of the mechanisms responsible for the attenuation of CSR seen with nasal CPAP.

The pulmonary physician in critical care * 2: oxygen delivery and consumption in the critically ill

Early detection and correction of tissue hypoxia is essential if progressive organ dysfunction and death are to be avoided. However, hypoxia in individual tissues or organs caused by disordered regional distribution of oxygen delivery or disruption of the processes of cellular oxygen uptake and utilisation cannot be identified from global measurements. Regional oxygen transport and cellular utilisation have an important role in maintaining tissue function. When tissue hypoxia is recognised, treatment must be aimed at the primary cause. Supplemental oxygen may be life saving in some situations but cannot correct inadequate oxygen delivery caused by a low cardiac output or impaired ventilation. Recent innovations include artificial oxygen carrying proteins and "haemoglobin" molecules designed to improve tissue blood flow by reducing viscosity. Regulating cell metabolism using different substrates or drugs has so far been poorly explored but is an exciting area for further research. A minimum level of global oxygen delivery and perfusion pressure must be maintained in the critically ill patient with established "shock", but advances in the understanding and control of regional distribution and other "downstream" factors in the oxygen cascade are needed to improve outcome in these patients.

Oxygen delivery and outcome

Perioperative haemodynamic optimization of high-risk surgical patients seems to be associated with a reduction in morbidity and mortality. There is, however, no evidence to support the use of treatment directed at achieving survivor values of oxygen delivery and consumption in critically ill patients after admission to intensive care. Mitochondrial dysfunction may be responsible for the inability of patients dying of sepsis to increase oxygen consumption and thus may explain why therapies directed at reducing mortality through increasing oxygen delivery have not been successful. In response to the recent controversy surrounding the risks versus benefits of pulmonary artery catheterization, current research is focusing on the development and evaluation of noninvasive methods to assess the adequacy of resuscitation.

Transient fall in oxygen intake during exercise in congestive heart failure

We report four cases in which oxygen intake abruptly decreased during a graded exercise test. In all these cases, there was an acute event (arrhythmia, mitral regurgitation) that had very likely resulted in a decrease in cardiac output. These studies provide new evidence of oxygen intake dependence on oxygen transport, even in nonsteady-state situations.

The relationship of oxygen consumption measured by indirect calorimetry to oxygen delivery in critically ill patients

OBJECTIVE

The existence of oxygen supply dependency, defined as oxygen consumption (VO2) limited by oxygen delivery (DO2), is still questioned. This study examined the relationship between VO2 and DO2 in two groups of critically ill surgical patients 50 years and older in the first 24 hours of resuscitation after pulmonary artery catheter insertion. Group 1 patients had systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, septic shock, and adult respiratory distress syndrome (ARDS). Group 2 patients had hemorrhagic shock.

METHODOLOGY

Study methodology included (1) augmenting DO2 with fluids, blood, and vasopressors, (2) measuring VO2 by indirect calorimetry to avoid the problem of mathematical coupling with DO2 calculation, and (3) analyzing data during steady states of temperature, sedation, paralyzing agents, and vasopressors.

RESULTS

Six to 18 measurements collected on all study patients during a period within the first 24 hours were analyzed using a linear regression analysis. Statistical significance was set at p < or = 0.05. Seven of nine patients in group 1 demonstrated positive, statistically significant relationships between VO2 and DO2. Of six patients in group 2, one patient demonstrated a positive, significant relationship of VO2 and DO2, three demonstrated inverse relationships, and two patients did not show a DO2/VO2 relationship. Supply dependency did not exist in all patients but was present in seven out of nine patients with systemic inflammatory response syndrome, sepsis, severe sepsis, septic shock, and adult respiratory distress syndrome in the first 24 hours of treatment.

Characterization of systemic oxygen transport in end-stage chronic congestive heart failure

Chronic congestive heart failure (CHF) is characterized by low cardiac index (CI) and low systemic oxygen delivery (DO2), which frequently are associated with lethal cardiogenic shock after acute myocardial infarction. Nevertheless, patients with severe CHF are able to survive with these low levels of systemic DO2 and CI. It was hypothesized that patients with CHF survive low CI and DO2 by downregulation of global metabolism and resting oxygen consumption (VO2) and a concomitant increase in systemic oxygen extraction ratio (O2ER). Therefore the objective of this study was to characterize the resting pattern of systemic oxygen transport (O2T) and utilization in patients with stable CHF. Seventeen patients with CHF (New York Heart Association functional class III or IV) for > or = 3 months and with left ventricular ejection fraction (EF) < 25% and whose condition was stable with conventional oral therapy were studied. The control group comprised 10 subjects (NYHA class I) who had coronary angiography and who were found to have normal left ventricular function and EF > 60%. Subjects underwent right-heart catheterization for measurement and calculation of hemodynamic and O2T variables (VO2, DO2, and O2ER). There were no significant differences in mean age (67 +/- 6 vs 64 +/- 17 years) or gender ratio (male:female 14:3 vs 7:3) between CHF and control groups, respectively. The cause of CHF was ischemic in 13 and idiopathic in 4 patients. There were 9 patients in NYHA class III and 8 in class IV.(ABSTRACT TRUNCATED AT 250 WORDS)

Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis

The effects of intravenous N-acetylcysteine on hepatic and systemic haemodynamics were investigated in 11 patients with stable cirrhosis (eight alcohol; two primary biliary cirrhosis; one cryptogenic). N-acetylcysteine administration had no effect on the mean heart rate or mean arterial blood pressure despite a significant fall in systemic and pulmonary vascular resistance. Cardiac index increased but estimated liver blood flow and portal venous pressure did not change significantly. Administration of N-acetylcysteine resulted in increased oxygen delivery to the tissues because of the increased cardiac index but this was not accompanied by a rise in either arteriovenous oxygen extraction ratio or mean tissue oxygen consumption. Therefore N-acetylcysteine administration seems to confer no haemodynamic benefit to patients with cirrhosis.

Hemodynamic effects of oxygen therapy in patients with acute exacerbations of chronic obstructive pulmonary disease

The effects of oxygen therapy in patients with stable COPD have been previously reported; however, the hemodynamic changes induced by oxygen therapy in patients during acute exacerbations of COPD are less well known. To investigate the hemodynamic effects of controlled oxygen therapy in patients with acute exacerbations of COPD shortly after arriving at the hospital, we studied 15 consecutive patients who came to the emergency room with acutely decompensated COPD that did not require mechanical ventilation. Patients were monitored with a pulmonary artery catheter and a radial artery catheter. Oxygen uptake was calculated by the modified Fick equation. Arterial and venous blood gas levels and hemodynamic parameters were measured while breathing room air (baseline) and after 30 min on oxygen therapy via face mask. Measurements were repeated after 24 and 48 h. The fractional concentration of oxygen in the inspired gas (FIO2) administered was adjusted to keep the PaO2 above 55 mm Hg. All patients had a PaO2 below 45 mm Hg at the beginning of the study. After 30 min of oxygen therapy, there was a significant (p < 0.05) increase in arterial oxygen saturation (from 62 +/- 16 to 87 +/- 9 percent), mixed-venous oxygen pressure (from 25 +/- 5 to 43 +/- 11 mm Hg), and oxygen delivery (from 11.1 +/- 3.7 to 19.3 +/- 8.9 ml/kg.min). Oxygen uptake did not change significantly (from 4.1 +/- 1.2 to 4.3 +/- 1.6 ml/kg.min). The oxygen extraction ratio decreased from 37.5 +/- 10.1 to 25.3 +/- 9.6 percent. These changes were maintained during the following 48 h. There were no significant changes in cardiac output and systemic vascular resistance. A trend toward lower values of pulmonary vascular resistance did not reach statistical significance. We conclude that oxygen therapy in patients with acute exacerbations of COPD that do not require mechanical ventilation increases oxygen delivery without changes in cardiac output or oxygen uptake.

Different effects of prostacyclin and phentolamine on delivery-dependent O2 consumption and skin microcirculation after cardiac surgery

Inadequate tissue oxygen uptake autoregulation has been reported during the first hours after extracorporeal circulation for cardiac surgery. In the present study, we examined whether a dependence of oxygen consumption (VO2) on oxygen delivery (DO2) can be detected 24 hr after cardiac surgery using two different vasodilating agents. Cardiac output in triplicate was measured by thermodilution. Oxygen saturation of arterial and mixed venous blood was measured using a CO-oximeter. Oxygen consumption was assessed from the reverse Fick equation. In addition skin blood flow was assessed continuously by laser Doppler flowmetry. To investigate the VO2/DO2 relationship in 15 patients an increase in cardiac output and DO2 of at least 15% was achieved by systemic vasodilatation with iv prostacyclin (5-10 ng.kg-1.min-1) or phentolamine (5-10 g.kg-1.min-1). Infusion of phentolamine produced a 29 +/- 2% (mean +/- SE) increase in DO2 which was associated with a 20 +/- 6% increase in VO2. In contrast, prostacyclin produced a 22 +/- 3% increase in DO2 without change in VO2. Phentolamine did not alter skin microvascular blood flow, whereas prostacyclin increased skin microvascular blood flow by 33 +/- 3%. The results of the present study demonstrate a supply-dependency of VO2 in clinically stable patients 24 hr after cardiac surgery, suggesting the presence of an inadequate tissue O2 uptake autoregulation. The type of the vasodilator used to increase DO2 seems to play an important role in detecting such a supply-dependency of VO2, as well as changes of skin blood flow.

Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure

We studied the acute hemodynamic effects of increasing nasal continuous positive airway pressure (CPAP) in 13 patients with acute decompensation of congestive heart failure. Heart rate, respiratory rate, pulmonary capillary wedge pressure, right atrial pressure, systemic blood pressure, and thermodilution cardiac outputs were measured at baseline, during, and after application of nasal CPAP at increasing pressures of 5, 10, and 15 cm H2O. Cardiac index, stroke volume, and oxygen delivery were calculated. Based on a significant change in cardiac output greater than or equal to 400 ml, seven patients were classified as responders, whereas six patients were considered to be nonresponders. In responders, significant increases were noted in cardiac index (2.5 +/- 0.7 to 2.9 +/- 0.9 L/min/m2), stroke volume (49 +/- 15 to 57 +/- 16 ml), and oxygen delivery (10.3 +/- 5.1 to 12.3 +/- 6.0 ml/min/kg) without a change in pulmonary capillary wedge pressure. In contrast, the nonresponders showed no significant change in any of the hemodynamic parameters. Improvement in cardiac output could not be predicted by any of the baseline hemodynamic or clinical variables, nor was it related to random variations since all variables returned to baseline after cessation of CPAP. Increase in stroke volume without a change in pulmonary capillary wedge pressure (preload) suggests either improved inotropic function of the left ventricle or reduced left ventricular afterload with CPAP. Thus, CPAP may offer a new noninvasive adjunct to improving left ventricular function and augmenting cardiac performance in a subset of patients with congestive heart failure.

Relationship of oxygen consumption and oxygen delivery in surgical patients with ARDS

Previous studies have described oxygen delivery (DO2) and oxygen consumption (VO2) relationships in patients with ARDS and other acute diseases that suggest occasions when VO2 may be dependent on the supply of oxygen, ie, DO2. We studied 127 postoperative patients who developed ARDS to evaluate the relationship of DO2 to VO2. We found a weak correlation between DO2 and VO2 in the total series (r = 0.49) as well as in several clinical subgroups of patients with ARDS. Moreover, we observed similar relationships in a concurrent group of 218 postoperative patients who did not develop ARDS. We also examined the DO2/VO2 data of individual patients with ARDS to identify instances where flow-dependent VO2 patterns developed into flow-independent VO2 patterns. We were able to identify an apparent plateau in the DO2/VO2 relationships in 29/50 (58 percent) patients where multiple measurements were obtained over a short period of time. Our data are consistent with the concept that the DO2/VO2 relationship in acutely ill early postoperative patients with and without ARDS is affected by antecedent circulatory problems that may lead to tissue hypoxia and tissue oxygen deficiencies that are manifest by flow dependency.

The dependency of oxygen consumption on oxygen delivery in critically ill postoperative patients is mimicked by variations in sedation

The finding of a dependence of oxygen consumption on oxygen delivery in critically ill patients has encouraged interventions to increase oxygen delivery index (DO2I) to overcome tissue hypoxia. In individuals other factors may influence oxygen consumption index (VO2I) and DO2I and may cause an apparently dependent relationship. We studied the effects of sedation and temperature on the VO2I/DO2I relationship in 13 perioperative patients. Pooled data showed significant correlations between VO2I and DO2I (r greater than 0.6, p less than 0.05) but also between VO2I and sedation score (r greater than 0.7, p less than 0.05), but not VO2I and temperature (r less than 0.5). When VO2I was standardized for the effects of sedation score (SS), the relationship between VO2I and DO2I was lost (r less than 0.5). Seven of 13 patients had significant (p less than 0.05) correlations between VO2I and SS and six of 13 between VO2I and DO2I; when standardized for the effect of varying sedation, no relationships were significant. When interpreting oxygen transport data from critically ill patients, the effects of sedation but not temperature must be taken into account; otherwise a false impression of a dependent relationship between VO2I and DO2I may cause unnecessary treatment.

Supply-dependent oxygen consumption and mixed venous oxyhemoglobin saturation during isovolemic hemodilution in pigs

To assess the responsiveness of mixed venous oximetry under conditions of supply-independent and supply-dependent oxygen consumption, we subjected ten pigs to graded isovolemic hemodilution while measuring cardiopulmonary variables, including oxygen consumption (VO2), oxygen delivery (DO2), and mixed venous oxyhemoglobin saturation (SvO2). Supply-dependent VO2 was reached at an average hemoglobin concentration of 3.9 +/- 0.7 g.dl-1, an SvO2 of 38.2 +/- 8.1 percent, and an oxygen extraction ratio of 0.55 +/- 0.10. The change in SvO2 corresponding to a 100-ml decrease in DO2 was -9.2 +/- 3.7 percent when VO2 was supply-independent and -7.6 +/- 5.2 percent when it was supply-dependent (NS). However, the rate of decline in SvO2 in the supply-dependent range was significantly slower than the rate calculated assuming unchanged VO2 (-32.6 +/- 16.3 percent; p less than 0.01). The results indicate that appearance of supply-dependence of VO2 does not render mixed venous oximetry unresponsive to further deterioration of oxygen supply during isovolemic hemodilution.

Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure

BACKGROUND

When administered early after an overdose of acetaminophen, intravenous acetylcysteine prevents hepatic necrosis by replenishing reduced stores of glutathione. How acetylcysteine improves the survival of patients with established liver damage induced by acetaminophen, however, is unknown. This study was undertaken to determine whether the beneficial effect of acetylcysteine under such circumstances could be due to enhancement of oxygen delivery and consumption.

METHODS

We studied the effect of acetylcysteine on systemic hemodynamics and oxygen transport in 12 patients with acetaminophen-induced fulminant hepatic failure and 8 patients with acute liver failure from other causes. The acetylcysteine was given in a dose of 150 mg per kilogram of body weight in 250 ml of 5 percent dextrose over a period of 15 minutes and then in a dose of 50 mg per kilogram in 500 ml of 5 percent dextrose over a period of 4 hours; measurements were made before treatment began and after 30 minutes of the regimen.

RESULTS

In the patients with acetaminophen-induced liver failure, the infusion of acetylcysteine resulted in an increase in mean oxygen delivery from 856 to 975 ml per minute per square meter of body-surface area (P = 0.0036), due to an increase in the cardiac index from 5.6 to 6.7 liters per minute per square meter (P = 0.0021). Mean arterial pressure rose from 88 to 95 mm Hg (P = 0.0054) despite a decrease in systemic vascular resistance from 1296 to 1113 dyn.sec.cm-5 per square meter (P = 0.027). There was an increase in oxygen consumption from 127 to 184 ml per minute per square meter (P = 0.0007) associated with an increase in the oxygen-extraction ratio from 16 to 21 percent (P = 0.022). The effects in the patients with acute liver failure from other causes were similar.

CONCLUSIONS

The increase in oxygen delivery and consumption in response to acetylcysteine may account for its beneficial effect on survival in patients with fulminant hepatic failure induced by acetaminophen.

Independent oxygen uptake and oxygen delivery in septic and postoperative patients

Previous studies reporting pathologic oxygen supply dependency calculated VO2 as CO x C(a-v)O2. We investigated whether pathologic oxygen supply dependency exists in septic and postoperative patients if VO2 and DO2 are assessed independently. In septic patients, VO2 was 164 +/- 31 and DO2 was 633 +/- 209 ml/min/m2. The slope (b) of the VO2-DO2 regression line VO2 = b x DO2 + a ranged from -0.10 to 0.08 (mean, 0.02 +/- 0.01, p less than 0.05) and was statistically significant in two patients (b = 0.05 and b = 0.08, p less than 0.05). In postoperative patients VO2 was 136 +/- 19 and DO2 was 481 +/- 160 ml/min/m2; b ranged from -0.07 to 0.09 (mean, 0.04 +/- 0.01, p less than 0.001) and was statistically significant in one patient (b = 0.09, p less than 0.01). The lack of a close relationship between independently measured VO2 and DO2 may indicate that septic and postoperative patients in stable hemodynamic condition have no pathologic oxygen supply dependency. Analysis of the VO2-DO2 relationship may not be useful to guide therapy or predict outcome.

Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome

We asked whether oxygen consumption is dependent on oxygen delivery in 17 patients who had severe adult respiratory distress syndrome (ARDS), 10 of whom had increased concentrations of plasma lactate. We determined oxygen consumption using analysis of respiratory gases while increasing oxygen delivery using blood transfusion. Oxygen consumption did not change after transfusion (from 227 +/- 83 to 225 +/- 82 ml/min, p less than or equal to 0.38). Oxygen delivery increased from 1,043 +/- 468 ml/min (24%, p less than or equal to 0.001). Even in the 10 patients who had increased concentration of plasma lactate and metabolic acidosis, oxygen consumption remained constant after increasing oxygen delivery (pretransfusion, 224 +/- 101 ml/min; post-transfusion, 225 +/- 99 ml/min; p less than or equal to 0.83). These data have more than 99% power of detecting a change in oxygen consumption of 20 ml/min after transfusion. Therefore, we conclude that directly measured oxygen consumption remains constant and independent of increases in oxygen delivery in our patients with severe ARDS. Because simultaneously determined oxygen consumption calculated from variables shared with the calculation of oxygen delivery yielded a dependent relationship, we speculate that finding dependence of calculated oxygen consumption on oxygen delivery may be the result of methodologic error.

Oxygen supply and utilization relationships. A reevaluation

The relationship between oxygen transport (TO2) and oxygen consumption (VO2) has been studied in patients with a number of acute and chronic disorders. Many of these patients have been shown to have a linear relationship between these two variables over a wide range of TO2, which has been considered as evidence of pathologic supply dependency. This supply dependency contrasts with animal studies that have clearly demonstrated a biphasic relationship between TO2 and VO2. This review of the available data concerning the relationship between oxygen transport and supply under conditions of increased oxygen requirements and reduced oxygen transport suggests the possibility that the observed interaction in patients may, in many cases, represent the normal physiologic behavior of the system rather than an abnormal manifestation of impaired oxygen extraction.

Long-term oxygen therapy in patients with diagnoses other than COPD

Long-term O2 prescription in chronic non-COPD hypoxic lung disease is, at present, based largely on physiological rather than on clinical studies. Controlled long-term studies in this field are difficult to perform. The cooperation of many centers is necessary to obtain a large and homogeneous population as the incidence of these diseases is significantly lower than COPD.

Oxygen delivery and oxygen uptake in postoperative and septic patients

Pathologic dependency of VO2 on DO2 has been reported in postoperative and septic patients. We studied the influence of an artifact due to calculation of VO2 from CO and AV content difference. In 13 postoperative and seven septic patients, the relationships between DO2 and cVO2 and between DO2 and mVO2 were analyzed by linear regression. In ten patients, cVO2 and DO2 were significantly correlated, but in only two of these patients mVO2 also correlated with DO2. In two patients, there was a significant correlation between mVO2 and DO2. The main contribution to the correlation and to the slope of the regression line between cVO2 and DO2 may be due to mathematic coupling of cVO2 and DO2. With cVO2, erroneous conclusions concerning the VO2-DO2 relationship may be drawn. In four patients, DO2 and mVO2 were significantly related, reflecting either physiologic coupling or pathologic supply dependency of VO2.

Oxygen transport and oxygen consumption during supplemental oxygen administration in patients with chronic obstructive pulmonary disease

PURPOSE

Oxygen consumption (VO2) is independent of oxygen delivery (DO2) above a critical level of DO2. VO2 may become dependent on DO2 when oxygen demand exceeds oxygen supply. We studied DO2 VO2, and exercise capacity in 12 stable, ambulatory patients with chronic obstructive pulmonary disease (COPD) receiving ambient air and 26% oxygen to ascertain whether VO2 is dependent on DO2 in this patient sample.

PATIENTS AND METHODS

An exercise protocol consisting of a symptom-limited, low-level treadmill test with progressive increments in workload was performed twice, once with patients breathing ambient air and once with patients breathing 26% oxygen. Expired gas, arterial and mixed venous blood values, and recordings of systemic and pulmonary artery pressures were obtained after a 10-minute period of rest (while standing) and during the last minute of each three-minute exercise level.

RESULTS

Five patients had an increase in exercise capacity, defined as an increase in the maximal VO2 greater than 25%, using supplemental oxygen. In these patients, oxygen delivery increased from 10.9 +/- 3.4 to 13.8 +/- 4.7 mL/minute/kg (p = 0.008) at rest and from 16.2 +/- 5.0 to 24.7 +/- 2.7 mL/minute/kg (p = 0.046) during exercise with supplemental oxygen administration. VO2 increased from 0.329 +/- 0.065 to 0.436 +/- 0.109 L/minute (p = 0.029) at rest and from 0.776 +/- 0.275 to 1.119 +/- 0.482 L/minute (p = 0.048) during exercise. Three of these five patients had an arterial oxygen pressure greater than 55 mm Hg at rest. Seven patients had little or no increase in exercise capacity with supplemental oxygen. This patient group had no increase in VO2 at rest. The DO2 failed to increase at rest despite an increase in arterial oxygen content because of a reduction in cardiac output.

CONCLUSION

These data demonstrate that DO2 may fail to increase in some patients with COPD and resting or exertional hypoxemia when supplemental oxygen is administered because of a reduction in cardiac output; that patients who fail to increase their DO2 are less likely to increase exercise capacity; and that some stable, ambulatory patients with COPD who do not qualify for supplemental oxygen at rest by current standards may have inadequate DO2 to meet physiologic needs.

Oxygen supply dependency in patients with obstructive sleep apnea and its reversal after therapy with nasal continuous positive airway pressure

Recently, it was shown that under certain conditions, there is a linkage between oxygen delivery (DO2) and oxygen consumption (VO2) so that any increase in DO2 is accompanied by an increase in VO2. We investigated this phenomenon in 10 patients with severe obstructive sleep apnea who had nocturnal oxygen desaturations to less than 85% (Group I), 10 patients with mild sleep apnea and no significant desaturations (Group II), and six obese control subjects (Group III). VO2 was measured by respired gas analysis before and after passive leg raising, which has been shown to increase DO2 by 10 to 12%. This was verified by thermodilution cardiac output measurements in four obese patients. In patients with severe sleep apnea, mean apnea index was 53 +/- 11, and supine VO2 was 141 +/- 40 ml/min/m2, whereas with leg elevation it rose to 163 +/- 41 ml/min/m2 (p less than 0.005). In patients with mild sleep apnea and in obese control subjects (mean apnea indices of 24 +/- 6 and 4 +/- 1, respectively), supine VO2 was 144 +/- 11 and 152 +/- 10 ml/min/m2, respectively; with leg elevation, VO2 was 144 +/- 13 and 151 +/- 6 ml/min/m2, respectively (p greater than 0.6). The study was repeated in nine of the Group I patients after 8 wk of treatment with nasal CPAP (Group IA). The repeated supine VO2 in these patients was 138 +/- 28 ml/min/m2, and a significant difference was not observed after leg raising (140 +/- 29 ml/min/m2; p greater than 0.5).(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of opposite changes in cardiac output and arterial PO2 on the relationship between mixed venous PO2 and oxygen transport

We examined the relationship between changes in systemic oxygen transport (SO2T) and mixed venous PO2 (PvO2) in nine critically ill patients with acute respiratory failure and analyzed the effect of like and opposite changes in cardiac output (CO) and arterial PO2 (PaO2) on this relationship. Paired measurements of oxygen consumption (VO2), SO2T, and PvO2 were obtained before and after changes in the level of positive end-expiratory pressure (PEEP) equal to or more than 5 cm H2O. VO2 was measured with a rebreathing circuit adapted to a volume ventilator, and SO2T was calculated from thermodilution CO, PaO2, SaO2, and hemoglobin. In eight studies, CO and PaO2 changed in the same direction, and the absolute change in SO2T averaged 48 +/- 38 ml/min/m2. In 12 studies, CO and PaO2 changed in opposite directions, and the absolute change in SO2T averaged 78 +/- 69 ml/min/m2. When PaO2 and CO changed in the same direction, PvO2 increased on the higher level of SO2T (average difference 3.0 +/- 3.7 mm Hg, p less than 0.05) and there was a strong positive correlation between the difference in SO2T on lower and higher levels of PEEP and the difference in PvO2 (r = 0.83). When PaO2 and CO changed in opposite directions, PvO2 was unchanged on the higher level of SO2T, and there was no correlation between the difference in SO2T on lower and higher levels of PEEP and the difference in PvO2 (r = -0.45). VO2 was not different at the lower and higher levels of SO2T in both groups, indicating that VO2 was not transport-limited in these patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Relationship between mixed venous oxygen saturation and cardiac index in patients with chronic congestive heart failure

The use of mixed venous oxygen saturation (SvO2) in patients with chronic congestive heart failure (CHF) has been advocated to analyze the action of therapy on cardiac index (CI). To evaluate the relationship between CI and SvO2, ten CHF patients (mean age 65 years) were studied before and one, two, three, four (T4), six, eight and 24 hours after oral administration of an angiotensin converting enzyme (ACE) inhibitor (perindopril, 4 mg). At T4, a 12 percent increase in CI (p less than 0.01) was associated with a 16 percent decrease in arteriovenous oxygen difference (p less than 0.01), a 13 percent increase in mixed venous oxygen pressure (PvO2) (p less than 0.01), and a 9 percent increase in SvO2 (p less than 0.05) with no significant change in arterial oxygen pressure. There was no correlation between CI and SvO2 (r = 0.22) and between CI and PvO2 (r = 0.23). Individual analyses were performed and patients were divided into two groups based on CI versus SvO2 r value; group 1, n = 6, r greater than 0.65 (0.65-0.90), group 2, n = 4, r less than 0.65 (0.14-0.20). The lack of correlation in group 2 was due to a drug-dependent increase in oxygen consumption (VO2) +18 percent vs -3 percent in group 1 (p less than 0.05) associated with a lack of increase in PvO2 +3 percent vs +14 percent in group 1 (p less than 0.05) despite a similar increase in oxygen availability +19 percent versus +16 percent. It was concluded that (1) a correlation between CI and SvO2 is not found in every patient with CHF; (2) the lack of correlation in four out of our ten patients was due to an associated and significant increase in CI and VO2 in group 2; (3) group 2 patients probably had an important oxygen debt before treatment; (4) SvO2 cannot be used instead of CI to determine the hemodynamic consequences of the use of cardiovascular drugs.

Relationship between oxygen uptake and oxygen delivery in patients with pulmonary hypertension

Dependency of oxygen consumption (VO2) on oxygen delivery (DO2) in patients with adult respiratory distress syndrome and with congestive heart failure has been reported previously. We evaluated this relationship in 11 patients with pulmonary hypertension, 8 with primary pulmonary hypertension (PPH), and 3 with pulmonary hypertension secondary to chronic obstructive lung disease (SPH) at baseline and during treatment with vasodilating calcium channel antagonists. The mean baseline DO2 and VO2 were 11.0 +/- 4.2 and 3.9 +/- 1.1 ml/min/kg, respectively. After increasing cardiac output via vasodilators, we obtained an average of 3 additional data points per patient. We found a significant relationship between changes in VO2 and changes in DO2 (delta VO2 = -0.19 +/- 0.27 x delta DO2; r = 0.88, n = 37). In 4 patients, VO2 was determined both by respired gas analysis and by calculation from thermodilution cardiac output and measured arteriovenous oxygen gradient; results by the 2 methods were virtually identical. There was no significant relationship between cardiac output and mixed venous oxygen content or mixed venous oxygen tension (r = 0.20 and 0.47, respectively). Mean baseline oxygen extraction ratio was 36.7 +/- 6.4% and did not increase significantly after vasodilator therapy. We conclude that in patients with pulmonary hypertension, changes in oxygen consumption appear to be dependent on changes in oxygen delivery. This may represent evidence of tissue hypoxemia, which is otherwise not apparent. This dependency may support the use of vasodilators in these patients.